She worked at a hospital in Fort Worth, TX, for 4 years as a dietitian, counseling those living with HIV.
Reduced cancer incidence, longer survival, and fewer metastases were also seen with GLP-1 use in patients with endometrial, bladder and prostate cancers, as well as in those with small intestine neoplasms and blood cancers, multiple studies found
She has been cited in The New York Times
Yes, especially during the first few months of treatment
More recent work from the Zagreb group has explored BPC-157 in the context of the gut-brain axis, investigating how its gastrointestinal effects may relate to broader systemic and neurological outcomes a line of inquiry that reflects growing scientific interest in enteric-central nervous system communication